Correlation Between Silverback Therapeutics and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Silverback Therapeutics and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silverback Therapeutics and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silverback Therapeutics and Champions Oncology, you can compare the effects of market volatilities on Silverback Therapeutics and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silverback Therapeutics with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silverback Therapeutics and Champions Oncology.
Diversification Opportunities for Silverback Therapeutics and Champions Oncology
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Silverback and Champions is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Silverback Therapeutics and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Silverback Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silverback Therapeutics are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Silverback Therapeutics i.e., Silverback Therapeutics and Champions Oncology go up and down completely randomly.
Pair Corralation between Silverback Therapeutics and Champions Oncology
Given the investment horizon of 90 days Silverback Therapeutics is expected to generate 1.1 times less return on investment than Champions Oncology. But when comparing it to its historical volatility, Silverback Therapeutics is 1.67 times less risky than Champions Oncology. It trades about 0.38 of its potential returns per unit of risk. Champions Oncology is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest 820.00 in Champions Oncology on November 3, 2024 and sell it today you would earn a total of 279.00 from holding Champions Oncology or generate 34.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Silverback Therapeutics vs. Champions Oncology
Performance |
| Timeline |
| Silverback Therapeutics |
| Champions Oncology |
Silverback Therapeutics and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Silverback Therapeutics and Champions Oncology
The main advantage of trading using opposite Silverback Therapeutics and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silverback Therapeutics position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Silverback Therapeutics vs. Zura Bio Limited | Silverback Therapeutics vs. Annexon | Silverback Therapeutics vs. In8bio Inc | Silverback Therapeutics vs. Wave Life Sciences |
| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |